These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 15890582)

  • 21. Modelling the variation in rectal dose due to inter-fraction rectal wall deformation in external beam prostate treatments.
    Booth J; Zavgorodni S
    Phys Med Biol; 2005 Nov; 50(21):5055-74. PubMed ID: 16237241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A failure detection strategy for intrafraction prostate motion monitoring with on-board imagers for fixed-gantry IMRT.
    Liu W; Luxton G; Xing L
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):904-11. PubMed ID: 20579818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intrafraction motion of the prostate during external-beam radiation therapy: analysis of 427 patients with implanted fiducial markers.
    Kotte AN; Hofman P; Lagendijk JJ; van Vulpen M; van der Heide UA
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):419-25. PubMed ID: 17513059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An endorectal balloon reduces intrafraction prostate motion during radiotherapy.
    Smeenk RJ; Louwe RJ; Langen KM; Shah AP; Kupelian PA; van Lin EN; Kaanders JH
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):661-9. PubMed ID: 22099035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dosimetric consequences of intrafraction prostate motion.
    Li HS; Chetty IJ; Enke CA; Foster RD; Willoughby TR; Kupellian PA; Solberg TD
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):801-12. PubMed ID: 18234439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of geometric uncertainties on evaluation of treatment techniques for prostate cancer.
    Craig T; Wong E; Bauman G; Battista J; Van Dyk J
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):426-36. PubMed ID: 15890584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rectal dose-volume differences using proton radiotherapy and a rectal balloon or water alone for the treatment of prostate cancer.
    Vargas C; Mahajan C; Fryer A; Indelicato D; Henderson RH; McKenzie C; Horne D; Chellini A; Lawlor P; Li Z; Oliver K; Keole S
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1110-6. PubMed ID: 17967305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does treatment of the pelvic nodes with IMRT increase late rectal toxicity over conformal prostate-only radiotherapy to 76 Gy?
    Sanguineti G; Cavey ML; Endres EJ; Franzone P; Barra S; Parker BC; Marcenaro M; Colman M; Agostinelli S; Foppiano F; Vitale V
    Strahlenther Onkol; 2006 Sep; 182(9):543-9. PubMed ID: 16944377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is IMRT needed to spare the rectum when pelvic lymph nodes are part of the initial treatment volume for prostate cancer?
    Sanguineti G; Cavey ML; Endres EJ; Brandon GG; Bayouth JE
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):151-60. PubMed ID: 16198066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient tolerance of rectal balloons in conformal radiation treatment of prostate cancer.
    Ronson BB; Yonemoto LT; Rossi CJ; Slater JM; Slater JD
    Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1367-70. PubMed ID: 16488552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prostate localization systems for prostate radiotherapy].
    de Crevoisier R; Lagrange JL; Messai T; M'Barek B; Lefkopoulos D
    Cancer Radiother; 2006 Nov; 10(6-7):394-401. PubMed ID: 17035061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Three-dimensional conformal external beam radiotherapy compared with permanent prostate implantation in low-risk prostate cancer based on endorectal magnetic resonance spectroscopy imaging and prostate-specific antigen level.
    Pickett B; Kurhanewicz J; Pouliot J; Weinberg V; Shinohara K; Coakley F; Roach M
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):65-72. PubMed ID: 16517094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced motion and improved rectal dosimetry through endorectal immobilization for prostate stereotactic body radiotherapy.
    de Leon J; Jameson MG; Rivest-Henault D; Keats S; Rai R; Arumugam S; Wilton L; Ngo D; Liney G; Moses D; Dowling J; Martin J; Sidhom M
    Br J Radiol; 2019 Jun; 92(1098):20190056. PubMed ID: 30912956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A prospective three-dimensional analysis about the impact of differences in the clinical target volume in prostate cancer irradiation on normal-tissue exposure. A potential for increasing the benefit/risk ratio.
    Hille A; Töws N; Schmidberger H; Hess CF
    Strahlenther Onkol; 2005 Dec; 181(12):789-95. PubMed ID: 16362789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measurement of intrafractional prostate motion using magnetic resonance imaging.
    Mah D; Freedman G; Milestone B; Hanlon A; Palacio E; Richardson T; Movsas B; Mitra R; Horwitz E; Hanks GE
    Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):568-75. PubMed ID: 12243837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A study to quantify the effectiveness of daily endorectal balloon for prostate intrafraction motion management.
    Wang KK; Vapiwala N; Deville C; Plastaras JP; Scheuermann R; Lin H; Bar Ad V; Tochner Z; Both S
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):1055-63. PubMed ID: 22115790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative treatment planning on localized prostate carcinoma conformal photon- versus proton-based radiotherapy.
    Mock U; Bogner J; Georg D; Auberger T; Pötter R
    Strahlenther Onkol; 2005 Jul; 181(7):448-55. PubMed ID: 15995838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intraoperative real-time planned conformal prostate brachytherapy: post-implantation dosimetric outcome and clinical implications.
    Zelefsky MJ; Yamada Y; Cohen GN; Sharma N; Shippy AM; Fridman D; Zaider M
    Radiother Oncol; 2007 Aug; 84(2):185-9. PubMed ID: 17692978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Late outcomes following hypofractionated conformal radiotherapy vs. standard fractionation for localized prostate cancer: a nonrandomized contemporary comparison.
    Leborgne F; Fowler J
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1441-6. PubMed ID: 19395194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mathematical model for evaluating incidence of acute rectal toxicity during conventional or hypofractionated radiotherapy courses for prostate cancer.
    Strigari L; Arcangeli G; Arcangeli S; Benassi M
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1454-60. PubMed ID: 18990503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.